Published in Proc Natl Acad Sci U S A on February 04, 2011
Sortase enzymes in Gram-positive bacteria. Mol Microbiol (2011) 1.37
Site-specific C-terminal and internal loop labeling of proteins using sortase-mediated reactions. Nat Protoc (2013) 1.25
Enzymatic labeling of proteins: techniques and approaches. Bioconjug Chem (2013) 1.18
Biological synthesis of circular polypeptides. J Biol Chem (2012) 1.03
Protein-protein fusion catalyzed by sortase A. PLoS One (2011) 1.01
M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins. Bioconjug Chem (2012) 1.00
Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists. Proc Natl Acad Sci U S A (2015) 0.91
Protein ligation in living cells using sortase. Traffic (2012) 0.90
Three-in-one chromatography-free purification, tag removal, and site-specific modification of recombinant fusion proteins using sortase A and elastin-like polypeptides. Angew Chem Int Ed Engl (2013) 0.88
Sortase-Mediated Transpeptidation for Site-Specific Modification of Peptides, Glycopeptides, and Proteins. J Carbohydr Chem (2012) 0.88
The use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer. ACS Cent Sci (2015) 0.86
Reprogramming the specificity of sortase enzymes. Proc Natl Acad Sci U S A (2014) 0.83
Isopeptide ligation catalyzed by quintessential sortase A: mechanistic cues from cyclic and branched oligomers of indolicidin. J Biol Chem (2011) 0.83
Site-specific protein modification using immobilized sortase in batch and continuous-flow systems. Nat Protoc (2015) 0.81
Semienzymatic cyclization of disulfide-rich peptides using Sortase A. J Biol Chem (2014) 0.81
Sortase-catalyzed initiator attachment enables high yield growth of a stealth polymer from the C terminus of a protein. Macromol Rapid Commun (2013) 0.77
Site-specific functionalization of proteins and their applications to therapeutic antibodies. Comput Struct Biotechnol J (2014) 0.77
N-PEGylation of a reverse turn is stabilizing in multiple sequence contexts, unlike N-GlcNAcylation. ACS Chem Biol (2011) 0.77
Enhanced thermal stability of lichenase from Bacillus subtilis 168 by SpyTag/SpyCatcher-mediated spontaneous cyclization. Biotechnol Biofuels (2016) 0.77
Site-Specific PEGylation of Therapeutic Proteins. Int J Mol Sci (2015) 0.76
Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates. MAbs (2016) 0.76
How PEGylation influences protein conformational stability. Curr Opin Chem Biol (2016) 0.75
Improved variants of SrtA for site-specific conjugation on antibodies and proteins with high efficiency. Sci Rep (2016) 0.75
The N-Terminal GYPSY Motif Is Required for Pilin-Specific Sortase SrtC1 Functionality in Lactobacillus rhamnosus Strain GG. PLoS One (2016) 0.75
Secretion of circular proteins using sortase. Methods Mol Biol (2014) 0.75
One-step purification and immobilization of extracellularly expressed sortase A by magnetic particles to develop a robust and recyclable biocatalyst. Sci Rep (2017) 0.75
Semisynthetic prion protein (PrP) variants carrying glycan mimics at position 181 and 197 do not form fibrils. Chem Sci (2017) 0.75
Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity. Chem Sci (2017) 0.75
Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev (2006) 4.88
Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov (2008) 4.32
Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif. Proc Natl Acad Sci U S A (1999) 3.90
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem (2004) 3.73
Sortagging: a versatile method for protein labeling. Nat Chem Biol (2007) 3.39
Nucleophilic catalysis of oxime ligation. Angew Chem Int Ed Engl (2006) 2.69
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
Peptide and protein PEGylation: a review of problems and solutions. Biomaterials (2001) 2.00
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. Bioconjug Chem (2001) 1.89
PEGylation of therapeutic proteins. Biotechnol J (2010) 1.80
Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science (2003) 1.77
Chemistry. Seamless proteins tie up their loose ends. Science (2006) 1.66
Site-specific N- and C-terminal labeling of a single polypeptide using sortases of different specificity. J Am Chem Soc (2009) 1.63
The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl (2010) 1.54
Circular proteins--no end in sight. Trends Biochem Sci (2002) 1.53
Crystal structure of Streptococcus pyogenes sortase A: implications for sortase mechanism. J Biol Chem (2009) 1.52
Site-specific protein modification on living cells catalyzed by Sortase. Chembiochem (2008) 1.39
Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII. Proc Natl Acad Sci U S A (2005) 1.37
A straight path to circular proteins. J Biol Chem (2009) 1.31
Circular beta-lactamase: stability enhancement by cyclizing the backbone. FEBS Lett (1999) 1.30
Expansion of the sortase-mediated labeling method for site-specific N-terminal labeling of cell surface proteins on living cells. Chem Commun (Camb) (2009) 1.21
Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. Proc Natl Acad Sci U S A (1991) 1.19
Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function. Proc Natl Acad Sci U S A (2008) 1.07
Rescuing a destabilized protein fold through backbone cyclization. J Mol Biol (2001) 1.03
Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J Biol Chem (2004) 1.02
Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex. Mol Cell (2009) 1.00
A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation. Bioconjug Chem (2005) 0.97
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor. Bioconjug Chem (2005) 0.94
Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin. Exp Hematol (1988) 0.90
Backbone cyclic insulin. J Pept Sci (2010) 0.83
Site-specific polymer attachment to a CCL-5 (RANTES) analogue by oxime exchange. J Am Chem Soc (2005) 0.83
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell (2007) 9.68
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 8.97
Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell (2006) 7.08
A membrane protein required for dislocation of misfolded proteins from the ER. Nature (2004) 5.39
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature (2008) 5.15
Haploid genetic screens in human cells identify host factors used by pathogens. Science (2009) 4.91
The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell (2010) 4.72
Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol (2006) 4.67
T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature (2002) 3.93
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol (2007) 3.72
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol (2008) 3.61
Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol (2002) 3.43
Sortagging: a versatile method for protein labeling. Nat Chem Biol (2007) 3.39
Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science (2011) 3.19
Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A (2005) 3.01
A microengraving method for rapid selection of single cells producing antigen-specific antibodies. Nat Biotechnol (2006) 2.94
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci (2012) 2.90
The known unknowns of antigen processing and presentation. Nat Rev Immunol (2008) 2.85
Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate. J Biol Chem (2004) 2.75
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. Structure (2006) 2.56
Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A (2002) 2.54
CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity (2011) 2.50
A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol Cell (2005) 2.43
Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J Infect Dis (2008) 2.40
SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins. Proc Natl Acad Sci U S A (2008) 2.38
Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol (2011) 2.23
Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J (2004) 2.23
A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J Biol Chem (2003) 2.22
A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J (2003) 2.18
SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER. J Cell Biol (2006) 2.13
Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells. J Am Chem Soc (2007) 2.10
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A (2004) 2.09
Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J Invest Dermatol (2006) 2.05
Concurrent detection of secreted products from human lymphocytes by microengraving: cytokines and antigen-reactive antibodies. Clin Immunol (2008) 2.03
Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol (2012) 2.00
Mechanisms, biology and inhibitors of deubiquitinating enzymes. Nat Chem Biol (2007) 1.90
Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins. Mol Cell Biol (2004) 1.86
A deubiquitinating activity is conserved in the large tegument protein of the herpesviridae. J Virol (2005) 1.85
Ubiquitin-like proteins. Annu Rev Biochem (2012) 1.84
The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol Cell (2009) 1.82
Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv Immunol (2006) 1.78
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib. Nat Methods (2005) 1.78
Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J (2008) 1.77
Structure of a herpesvirus-encoded cysteine protease reveals a unique class of deubiquitinating enzymes. Mol Cell (2007) 1.75
Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science (2010) 1.74
Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem (2004) 1.74
Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature (2006) 1.73
XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells. EMBO J (2009) 1.72
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J Neurochem (2005) 1.71
Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe (2009) 1.69
Protein quality control in the ER: balancing the ubiquitin checkbook. Trends Cell Biol (2011) 1.68
Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med (2002) 1.64
Site-specific N- and C-terminal labeling of a single polypeptide using sortases of different specificity. J Am Chem Soc (2009) 1.63
Murine polyomavirus requires the endoplasmic reticulum protein Derlin-2 to initiate infection. J Virol (2006) 1.62
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc Natl Acad Sci U S A (2004) 1.59
Making and breaking peptide bonds: protein engineering using sortase. Angew Chem Int Ed Engl (2011) 1.58
Screen for ISG15-crossreactive deubiquitinases. PLoS One (2007) 1.57
The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance. EMBO J (2007) 1.56
Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One (2008) 1.55
A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromised. EMBO J (2004) 1.53
Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9. Eur J Immunol (2011) 1.52
High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: mutant viruses altered in its active-site cysteine or histidine are viable. J Virol (2006) 1.52
A functional proteomics approach links the ubiquitin-related modifier Urm1 to a tRNA modification pathway. Proc Natl Acad Sci U S A (2008) 1.51
Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol (2002) 1.50
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. J Immunol (2005) 1.50
Identification of host cell factors required for intoxication through use of modified cholera toxin. J Cell Biol (2011) 1.47
The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. J Biol Chem (2003) 1.46
Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. Mol Biol Cell (2004) 1.44
Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc Natl Acad Sci U S A (2008) 1.43
Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev (2005) 1.43
Site-specific protein labeling via sortase-mediated transpeptidation. Curr Protoc Protein Sci (2009) 1.43
Using a small molecule inhibitor of peptide: N-glycanase to probe its role in glycoprotein turnover. Chem Biol (2004) 1.42
Quality and quantity control at the endoplasmic reticulum. Curr Opin Cell Biol (2010) 1.42
The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog (2012) 1.41
Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr Opin Lipidol (2008) 1.40
Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells. Cancer Res (2005) 1.39
Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein. EMBO J (2002) 1.39
Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response. J Biol Chem (2005) 1.39
Preparation of unnatural N-to-N and C-to-C protein fusions. Proc Natl Acad Sci U S A (2012) 1.38
Granulin is a soluble cofactor for toll-like receptor 9 signaling. Immunity (2011) 1.36
Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol (2002) 1.36
Preferred in vivo ubiquitination sites. Bioinformatics (2004) 1.36
The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J Virol (2008) 1.35
Lipid modification of proteins through sortase-catalyzed transpeptidation. J Am Chem Soc (2008) 1.34
Enzymatic blockade of the ubiquitin-proteasome pathway. PLoS Biol (2011) 1.33
A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr Opin Immunol (2002) 1.32